Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiology, heart failure, electrophysiology, hypertension, structural heart disease, use of pharmaceuticals, and COVID-19.   

RSS icon

New MRI findings may explain why some amputees struggle with phantom pain

New research refutes the notion that parts of the brain controlling specific extremities remap themselves following amputation, which would prevent patients from feeling pain associated with the removed appendage. 

Eko Health announced former U.S. Surgeon General Jerome Adams, MD, MPH, FASA, a board-certified anesthesiologist and executive director of the Center for Community Health Enhancement and Learning at Purdue University, joined the company as a distinguished medical advisor.

Former US surgeon general joins Eko as medical advisor

"Eko is transforming how we detect cardiovascular disease—making cutting-edge, AI-powered tools accessible to frontline providers," said former U.S. Surgeon General Jerome Adams, MD.

The U.S. Food and Drug Administration (FDA) updated the Breakthrough Device Program designations data this week, which now includes 1,176 Breakthrough Device designations, of which 160 have gained market clearance. Cardiovascular devices lead these with 243 devices, the highest number out of all other clinical categories. This includes 16 new cardiovascular devices cleared in the past year.

Cardiovascular device approvals continue to lead the FDA's Breakthrough Device Program

Cardiology is number one in FDA Breakthrough Device designations at 218, the highest number out of all other clinical categories. This includes 16 new devices cleared in the past year.

FTC challenge to Edwards JenaValve acquisition could delay FDA approval

Edwards Lifesciences asked the U.S. Federal Trade Commission (FTC) this week to dismiss the complaint against the company's acquisition of JenaValve this week. A healthcare market analysis firm also said the FTC actions will likely impact the timing of an FDA clearance of the Trilogy heart valve.

radiology trends lungs imaging graphs

FDA clears new trial of first-in-class treatment for pulmonary arterial hypertension

The new drug, VTB-10, previously received the FDA's orphan drug designation in 2024.

Epic partners with Microsoft to roll out AI-powered clinical scribe

Epic confirmed on Tuesday that its long-rumored AI scribe feature is a reality. The company said it’s working with Microsoft-owned Nuance—and with clinical documentation standout Abridge—to add the feature to its platform.

Kenzie Thompson, BSN, RCIS, cardiovascular invasive specialist, St. Luke's Mid-America Heart Institute, shares advice she gave to cath lab technologists and nurses during a session at the Transcatheter Cardiovascular Therapeutics (TCT) meeting.

How to prepare for cath lab complications

“It is your responsibility to be the patient’s advocate,” one expert explained. “We, as the nurses and technologists, have to speak up when we see something that isn’t right.”

The Amplatzer Piccolo Occluder for transcatheter patent ductus arteriosus (PDA) closure in premature infants. Photo courtesy of Abbott.

SCAI details best practices for PDA closure in premature infants

Transcatheter patent ductus arteriosus (PDA) closure has been a mainstay in congenital interventional cardiology for decades, but changes in the standard of care have resulted in catheter-based treatments overtaking surgical procedures. 

Displaying 321 - 328 of 6900
Design by Adaptive Theme